Overview

Sildenafil Citrate for the Treatment of Established Pre-Eclampsia

Status:
Terminated
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy and safety of sildenafil citrate in the treatment of established pre-eclampsia
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Citric Acid
Sildenafil Citrate